BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8315212)

  • 1. Pharmacological separation of cardio-accelerator and vagal inhibitory capacities of sympathetic nerves.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Apr; 43(1):7-16. PubMed ID: 8315212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization by neuropeptide Y of effects of sympathetic stimulation on cardiac vagal action in anaesthetised dogs.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Oct; 45(1):21-8. PubMed ID: 8227962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.
    Hall GT; Gardner TD; Potter EK
    Circ Res; 1990 Jul; 67(1):193-8. PubMed ID: 2364490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
    Potter EK; McCloskey DI
    Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog.
    Gardner TD; Potter EK
    J Physiol; 1988 Nov; 405():115-22. PubMed ID: 3255790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.
    Moriarty M; Gibbins IL; Potter EK; McCloskey DI
    Neurosci Lett; 1992 May; 139(2):275-9. PubMed ID: 1376882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs.
    Revington ML; McCloskey DI
    J Physiol; 1990 Sep; 428():359-70. PubMed ID: 2231416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat.
    Smith-White MA; Wallace D; Potter EK
    J Auton Nerv Syst; 1999 Feb; 75(2-3):171-5. PubMed ID: 10189119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
    Warner MR; Levy MN
    Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats.
    Revington M; Potter EK; McCloskey DI
    J Physiol; 1990 Dec; 431():495-503. PubMed ID: 1712845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
    Ilebekk A; Björkman JA; Nordlander M
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
    Mahns DA; Lacroix JS; Potter EK
    J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagal action on atrioventricular conduction and its inhibition by sympathetic stimulation and neuropeptide Y in anaesthetised dogs.
    Pirola FT; Potter EK
    J Auton Nerv Syst; 1990 Sep; 31(1):1-12. PubMed ID: 2262662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine.
    Modin A; Pernow J; Lundberg JM
    J Auton Nerv Syst; 1994 Oct; 49(2):123-34. PubMed ID: 7806765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus.
    Potter EK
    J Auton Nerv Syst; 1987 Nov; 21(1):87-90. PubMed ID: 3440821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush-tailed possum Trichosurus vulpecula.
    Courtice GP; Potter EK; McCloskey DI
    J Physiol; 1993 Feb; 461():379-86. PubMed ID: 7688807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat.
    Pernow J; Thorén P; Millberg BI; Lundberg JM
    Acta Physiol Scand; 1988 Sep; 134(1):53-9. PubMed ID: 3239423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J; Kahan T; Lundberg JM
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen.
    Lundberg JM; Pernow J; Fried G; Anggärd A
    Acta Physiol Scand; 1987 Sep; 131(1):1-10. PubMed ID: 2890260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y?
    Potter EK
    Neurosci Lett; 1985 Mar; 54(2-3):117-21. PubMed ID: 2859560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.